Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.

Description

Pluto was founded in 2021 by the Wyss Institute of Harvard University. It has been a trusted partner for many life sciences organizations across the country, from biotech start-ups and public biopharma companies. Our cloud-based platform allows scientists to manage all their data, run bioinformatics analysis, and create interactive visualizations that are published-quality. The platform is being used for a variety of biological applications. These include preclinical and translational science research, cell and gene therapies and drug discovery and development.

API Access

Has API No 

API Access

Has API Yes 

Screenshots View All

Screenshots View All

Integrations

Airtable No 
BaseSpace Sequence Hub No 
Benchling No 
Microsoft PowerPoint No 
Microsoft Word No 
Notion No 
Okta No 
Smartsheet No 
Superhuman Docs No 

Integrations

Airtable Yes 
BaseSpace Sequence Hub Yes 
Benchling Yes 
Microsoft PowerPoint Yes 
Microsoft Word Yes 
Notion Yes 
Okta Yes 
Smartsheet Yes 
Superhuman Docs Yes 

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Pricing Details

Tailored packages for companies and labs of all sizes.
Free Trial Yes 
Free Version No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Customer Support

Business Hours Yes 
Live Rep (24/7) Yes 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars Yes 
Live Training (Online) No 
In Person Yes 

Types of Training

Training Docs Yes 
Webinars Yes 
Live Training (Online) Yes 
In Person Yes 

Vendor Details

Company Name

Atomwise

Founded

2012

Country

United States

Website

www.atomwise.com

Vendor Details

Company Name

Pluto Biosciences

Founded

2021

Country

United States

Website

pluto.bio

Product Features

Product Features

Scientific Data Management System (SDMS)

Analytics No 
Artificial Intelligence (AI) No 
Audit No 
Centralized Data Repository No 
Collaboration No 
Compliance No 
Data Security No 
ELN Integration No 
LIMS Integration No 
Workflows No 

Alternatives

Alternatives

StarDrop Reviews

StarDrop

Optibrium
AIDDISON Reviews

AIDDISON

Merck KGaA